Latest ebit for THMO: $-6M, below the Technology sector average of $12T.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024
The latest EBIT for THMO is $-6M as of March 2024. That compares with $-6M in the prior-year period — down 0.3% year over year. That is below the Technology sector average of $12T. Investors often review this figure alongside ThermoGenesis Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, THMO's EBIT moved from $-6M to $-6M — a 0.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ThermoGenesis Holdings's operating scale or balance-sheet position.
Against Technology companies, THMO currently prints $-6M for EBIT, while the sector average sits near $12T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at ThermoGenesis Holdings's growth, margins, and balance sheet.
A EBIT figure of $-6M for THMO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $12T. Explore the charts below for those layers of context.
After noting THMO's EBIT ($-6M), review year-over-year change from $-6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.